Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Clinical outcomes following a switch from Remicade® to the biosimilar CT-P13 in inflammatory bowel disease patients: a prospective observational cohort study.

Smits LJ, Derikx LA, de Jong DJ, Boshuizen RS, van Esch AA, Drenth JP, Hoentjen F.

J Crohns Colitis. 2016 Apr 19. pii: jjw087. [Epub ahead of print]

PMID:
27095751
2.

Probiotics and prebiotics in ulcerative colitis.

Derikx LA, Dieleman LA, Hoentjen F.

Best Pract Res Clin Gastroenterol. 2016 Feb;30(1):55-71. doi: 10.1016/j.bpg.2016.02.005. Epub 2016 Feb 9. Review.

PMID:
27048897
3.

Is the prevalence of colonic neuroendocrine tumors increased in patients with inflammatory bowel disease?

Derikx LA, Vierdag WA, Kievit W, Bosch S, Hoentjen F, Nagtegaal ID.

Int J Cancer. 2016 Mar 17. doi: 10.1002/ijc.30096. [Epub ahead of print]

PMID:
26992110
4.

Endoscopy in patients with diarrhea during treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitors: Is the cause in the mucosa?

Boers-Sonderen MJ, Mulder SF, Nagtegaal ID, Derikx LA, Wanten GJ, Mulders PF, van der Graaf WT, Hoentjen F, van Herpen CM.

Acta Oncol. 2016 Apr;55(4):444-8. doi: 10.3109/0284186X.2015.1119883.

PMID:
26959411
5.

Controversies in Pouch Surveillance for Patients with Inflammatory Bowel Disease.

Derikx LA, Nissen LH, Oldenburg B, Hoentjen F.

J Crohns Colitis. 2016 Jan 28. pii: jjw035. [Epub ahead of print]

PMID:
26822612
6.

Adalimumab drug survival in patients with psoriasis, Crohn's disease, and rheumatoid arthritis: Relevant differences using the same treatment.

van den Reek JM, Pijls PA, Tummers M, van Riel PC, Kievit W, Hoentjen F, de Jong EM.

J Am Acad Dermatol. 2016 Jan;74(1):177-9. doi: 10.1016/j.jaad.2015.08.010. No abstract available.

PMID:
26702800
7.

Safety of Tioguanine During Pregnancy in Inflammatory Bowel Disease.

van den Berg SA, de Boer M, van der Meulen-de Jong AE, Jansen JM, Hoentjen F, Russel MG, Mahmmod N, van Bodegraven AA, van der Woude CJ, Mulder CJ, de Boer NK.

J Crohns Colitis. 2016 Feb;10(2):159-65. doi: 10.1093/ecco-jcc/jjv189. Epub 2015 Oct 26.

PMID:
26503525
8.

Better survival of renal cell carcinoma in patients with inflammatory bowel disease.

Derikx LA, Nissen LH, Drenth JP, van Herpen CM, Kievit W, Verhoeven RH, Mulders PF, Hulsbergen-van de Kaa CA, Boers-Sonderen MJ, van den Heuvel TR, Pierik M, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis; PALGA Group; IBD/RCC Group.

Oncotarget. 2015 Nov 10;6(35):38336-47. doi: 10.18632/oncotarget.5186.

9.

Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.

Derikx LA, Nissen LH, Smits LJ, Shen B, Hoentjen F.

Clin Gastroenterol Hepatol. 2015 Sep 25. pii: S1542-3565(15)01304-X. doi: 10.1016/j.cgh.2015.08.042. [Epub ahead of print]

PMID:
26407752
10.

LPS-Stimulated Whole Blood Cytokine Production Is Not Related to Disease Behavior in Patients with Quiescent Crohn's Disease.

Broekman MM, Roelofs HM, Hoentjen F, Wiegertjes R, Stoel N, Joosten LA, de Jong DJ, Wanten GJ.

PLoS One. 2015 Jul 24;10(7):e0133932. doi: 10.1371/journal.pone.0133932. eCollection 2015.

11.

Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.

Broekman MM, Roelofs HM, Wong DR, Kerstholt M, Leijten A, Hoentjen F, Peters WH, Wanten GJ, de Jong DJ.

Cell Biol Toxicol. 2015 Jun;31(3):161-71. doi: 10.1007/s10565-015-9301-1. Epub 2015 Apr 28.

12.

Epstein-Barr virus in inflammatory bowel disease: the spectrum of intestinal lymphoproliferative disorders.

Nissen LH, Nagtegaal ID, de Jong DJ, Kievit W, Derikx LA, Groenen PJ, van Krieken JH, Hoentjen F.

J Crohns Colitis. 2015 May;9(5):398-403. doi: 10.1093/ecco-jcc/jjv040. Epub 2015 Mar 4.

PMID:
25740811
13.

GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease.

Broekman MM, Bos C, Te Morsche RH, Hoentjen F, Roelofs HM, Peters WH, Wanten GJ, de Jong DJ.

J Hum Genet. 2014 Oct;59(10):575-80. doi: 10.1038/jhg.2014.77. Epub 2014 Sep 4.

PMID:
25186055
14.

Cuff and pouch cancer in patients with inflammatory bowel disease: what surveillance strategy should be recommended?

Derikx LA, Hoentjen F.

Inflamm Bowel Dis. 2014 Aug;20(8):E20. doi: 10.1097/MIB.0000000000000095. No abstract available.

PMID:
24918324
15.

Management of Crohn's disease in poor responders to adalimumab.

de Boer NKh, Löwenberg M, Hoentjen F.

Clin Exp Gastroenterol. 2014 Apr 11;7:83-92. doi: 10.2147/CEG.S47627. eCollection 2014. Review.

16.

Golimumab for the treatment of ulcerative colitis.

Löwenberg M, de Boer NKh, Hoentjen F.

Clin Exp Gastroenterol. 2014 Mar 12;7:53-9. doi: 10.2147/CEG.S48741. eCollection 2014. Review.

17.

Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.

Derikx LA, Kievit W, Drenth JP, de Jong DJ, Ponsioen CY, Oldenburg B, van der Meulen-de Jong AE, Dijkstra G, Grubben MJ, van Laarhoven CJ, Nagtegaal ID, Hoentjen F; Dutch Initiative on Crohn and Colitis.

Gastroenterology. 2014 Jan;146(1):119-28.e1. doi: 10.1053/j.gastro.2013.09.047. Epub 2013 Sep 25.

PMID:
24076060
18.

[Ileo-anal pouch for inflammatory intestinal disease].

Derikx LA, Heikens JT, van Laarhoven CJ, Hoentjen F.

Ned Tijdschr Geneeskd. 2013;157(39):A5553. Review. Dutch.

PMID:
24063669
19.

[Treatment of patients with severe glucocorticoid-refractory ulcerative colitis: cyclosporine or infliximab?].

Löwenberg M, de Boer NK, Dewint P, Hoentjen F.

Ned Tijdschr Geneeskd. 2013;157(38):A6130. Review. Dutch.

PMID:
24050446
20.

Severe exacerbation of Crohn's disease during sunitinib treatment.

Boers-Sonderen MJ, Mulder SF, Nagtegaal ID, Jacobs JF, Wanten GJ, Hoentjen F, van Herpen CM.

Eur J Gastroenterol Hepatol. 2014 Feb;26(2):234-6. doi: 10.1097/MEG.0b013e328365ac54.

PMID:
24025975
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk